Evidence map›Paper›PMID 41869314›Full record

ArticleFrontiers in immunology2026

IgM-mediated protection drives early B-cell activation and mucosal containment of

Naomi Croft Guslund, Alexandra Jonsson, Anders K Krabberød, Adrián López-Porras, Simen F Nørstebø, Henning Sørum, Kjetill S Jakobsen, Finn-Eirik Johansen, Shuo-Wang Qiao

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Naomi Croft GuslundSection for Physiology and Cell Biology, Department of Biosciences, University of Oslo, Oslo, Norway.
Alexandra JonssonSection for Physiology and Cell Biology, Department of Biosciences, University of Oslo, Oslo, Norway.
Anders K KrabberødSection for Genetics and Evolutionary Biology, Department of Biosciences, University of Oslo, Oslo, Norway.
Adrián López-PorrasSection for Physiology and Cell Biology, Department of Biosciences, University of Oslo, Oslo, Norway.
Simen F NørstebøDepartment of Preclinical Sciences and Pathology, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, Ås, Norway.
Henning SørumDepartment of Paraclinical Sciences, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, Ås, Norway.
Kjetill S JakobsenCentre for Ecological and Evolutionary Synthesis, Department of Biosciences, University of Oslo, Oslo, Norway.
Finn-Eirik Johansen *Section for Physiology and Cell Biology, Department of Biosciences, University of Oslo, Oslo, Norway.
Shuo-Wang Qiao *Department of Immunology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atlantic cod lack functional MHC class II and CD4, raising fundamental questions about how vaccination generates protection in this species. Methods: We combined single-cell transcriptomic profiling of splenic cells with qRT-PCR across complementary active vaccination and passive serum-transfer experiments to define cellular and transcriptional correlates of immunity to Results: Bath-vaccinated fish and recipients of immune serum showed effective containment of infection, with bacterial signals largely restricted to gills and minimal detection in spleen or head kidney, whereas naïve fish frequently developed high systemic bacterial loads by day 3 post-infection. All groups exhibited increased splenic macrophage abundance following challenge, but only naïve fish showed strong and sustained inflammatory activation, consistent with their higher pathogen burden. Vaccinated fish and immune-serum recipients displayed only transient or weak myeloid responses despite similar early neutrophil activation. Across both experimental models, a transcriptionally distinct B-cell subset expanded at the peak of infection. This population showed increased immunoglobulin and MHC class I expression together with innate sensing features, consistent with an activated B-cell state. Although this B-cell subset increased in all groups, the largest expansions were observed in vaccinated fish and immune-serum recipients. Overall, these findings are consistent with antigen-specific IgM enhancing early B-cell activation and contributing to protection against Discussion: These findings identify an antibody-driven mode of immune coordination that operates independently of classical CD4

Indexed as

Antibodies, BacterialB-LymphocytesFish DiseasesGadus morhuaImmunoglobulin MLymphocyte ActivationVibrioVibrio InfectionsAnimalsBacterial VaccinesImmunity, MucosalVaccinationAntibodies, BacterialBacterial VaccinesImmunoglobulin MAtlantic codB cellsIgMinnate immunitysingle-cell RNA sequencingvaccinationVibrio anguillarum

Identifiers

PMID41869314
PMCPMC13002412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.